Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon P Gockerman

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Occult primaryDavid S Ettinger, Mark Agulnik, Mihaela Cristea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter StudyLeora Horn, Jeffrey R Infante, Karen L Reckamp, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
NCCN Clinical Practice Guidelines Occult primaryDavid S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphomaStephen J Schuster, Sattva S Neelapu, Barry L Gause, et al.
Clinical Lymphoma|July 2, 2005
Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim reportSattva S Neelapu, Barry L Gause, Daniel A Nikcevich, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 2, 2006
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncologyAndrew D Zelenetz, Ranjana H Advani, Francis Buadi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 25, 2008
Non-Hodgkin's lymphomasAndrew D Zelenetz, Ranjana H Advani, John C Byrd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2011
Non-Hodgkin's lymphomasAndrew D Zelenetz, Jeremy S Abramson, Ranjana H Advani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2010
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomasAndrew D Zelenetz, Jeremy S Abramson, Ranjana H Advani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2012
Non-Hodgkin's Lymphomas, version 3.2012Andrew D Zelenetz, William G Wierda, Jeremy S Abramson, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Occult primaryDavid S Ettinger, Mark Agulnik, Mihaela Cristea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter StudyLeora Horn, Jeffrey R Infante, Karen L Reckamp, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 14, 2011
NCCN Clinical Practice Guidelines Occult primaryDavid S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphomaStephen J Schuster, Sattva S Neelapu, Barry L Gause, et al.
Clinical Lymphoma|July 2, 2005
Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim reportSattva S Neelapu, Barry L Gause, Daniel A Nikcevich, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 2, 2006
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncologyAndrew D Zelenetz, Ranjana H Advani, Francis Buadi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 25, 2008
Non-Hodgkin's lymphomasAndrew D Zelenetz, Ranjana H Advani, John C Byrd, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2011
Non-Hodgkin's lymphomasAndrew D Zelenetz, Jeremy S Abramson, Ranjana H Advani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 6, 2010
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomasAndrew D Zelenetz, Jeremy S Abramson, Ranjana H Advani, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 11, 2012
Non-Hodgkin's Lymphomas, version 3.2012Andrew D Zelenetz, William G Wierda, Jeremy S Abramson, et al.
Pageof 6